Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures

Clinical trial NCT05288283 · TERMINATED

Trial details

NCT number: NCT05288283
Sponsor: Jazz Pharmaceuticals
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Seizures Associated With EMAS

Start date: 2022-10-31
Primary completion: 2023-09-28
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.